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Summary Diethylnitrosamine (DENA, 10mgkg-I per day) was fed to rats for 2, 4 and 6 weeks. One week
after the cessation of DENA, animals were submitted either to partial hepatectomy or to phenobarbital
administration. Partial hepatectomy did not promote neoplastic transformation, except after a 6-week DENA
treatment. A minimum of phenobarbital was required to reach a significant promoting effect in DENA
carcinogenesis. A too-limited treatment was ineffectual but could be compensated for by prolonged DENA
administration. The phenobarbital treatment became unnecessary when neoplastic nodules were present.
Phenobarbital continuously given after the carcinogen administration promoted neoplastic transformation
even after a subcarcinogenic DENA treatment (2 weeks). It accelerated the pathological evolution and
increased the tumour incidence. In these conditions, phenobarbital increased the proliferation advantage of
preneoplastic cells over normal cells. In the different experimental modalities, the promoting effect was
associated with the induction of chronic cell proliferation, the inhibition of the rapid response to the 2/3
partial hepatectomy and the mitotic circadian rhythm normally present during liver regeneration. It is
concluded that the promotion mechanism could consist in disturbing the mitotic control in order to maintain,
for a long time, a chronic low level of cell proliferation permitting the selective growth of preneoplastic cells
and their subsequent transformation.
During hepatic carcinogenesis in rats fed with
diethylnitrosamine (DENA), three successive steps
are observed (Squire & Levitt, 1975). (1) Foci of
putative preneoplastic cells, differing from the
surrounding liver parenchyma by various
histochemical reactions such as PAS positivity
demonstrating glycogen retention after fasting
(Bannasch, 1976)); (2) Neoplastic nodules capable of
autonomous growth but lacking properties of
malignant lesions; and (3) Unequivocal
hepatocarcinomas.
Though the precise relationship between these
steps is still unsettled, it is thought that the relative
resistance of the putative preneoplastic cells to the
cytotoxic action of carcinogen is responsible for
their selective growth until they reach the critical
size of neoplastic nodules (Rabes & Szymkowiak,
1979; Farber, 1980; Pitot & Sirica, 1980; Barbason
& Betz, 1981).
This proliferative advantage over the normal
tissue has been demonstrated during continuous
administration of DENA (Rabes & Szymkowiak,
1979). It has also been found to persist for a long
preneoplastic period after cessation of DENA
administration (Barbason & Betz, 1981). Moreover,
the first development of these preneoplastic lesions
is followed in different experimental models by a
latency period preceding their neoplastic
transformation (Sherer & Emmelot, 1976). This last
step towards cancer may be shortened by a
promoting activity of either carcinogens or
promoting agents (Solt & Farber, 1976; Pitot et al.,
1978; Barbason et al., 1975, 1976, 1977, 1979;
Barbason & Betz, 1980, 1981).
We have previously described an experimental
model which is in agreement with the two-stage
process of hepatocarcinogenesis recently proposed
(Farber, 1980; Pitot & Sirica, 1980; Emmelot &
Sherer, 1980). Preneoplastic foci induced by a
continuous DENA administration over less than
one month persist without further tumour
development and could correspond to initiation. On
the contrary, a treatment of DENA protracted for a
second month induces an evolution of the foci into
neoplastic nodules. This could be interpreted as
promotion following initiation. Afterwards, the
pathological evolution towards carcinoma is
autonomous and further carcinogen administration
is unnecessary (Barbason et al., 1976, 1977, 1979;
Barbason & Betz, 1980, 1981). In these experiments,
a good correlation was found between the
promotion stage and a disturbance in mitotic
control of the normal liver tissue.
We have suggested also that the initiation stage,
which is able to induce preneoplastic cells, would
not be sufficient to reach the "growth pressure" (see
Rabes & Szymkowiak, 1979) allowing the
development of preneoplastic lesions into
malignancy. The promoting stage characterized by
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an autonomous growth necessary to express the
malignancy would respond to a depression of the
mitotic control of the whole hepatic parenchyma
(Barbason & Betz, 1981, 1982).
To obtain more information about these
mechanisms, it would be of interest to use a
promoter which differs from the initiator. Various
promoters have been tested in other experimental
models, but very little is known about their
mechanism of action in hepatocarcinogenesis (Solt
& Farber, 1976; Peraino et al., 1975; Scherer &
Emmelot, 1975; Pitot et al., 1978; Taper, 1978).
However, the common activity whereby they are
considered to act is upon cell replication.
Here we compare the effect of partial
hepatectomy with that of phenobarbital
administration after 2, 4 or 6 weeks DENA feeding.
Both induce cell proliferation but are known to
potentiate the two stages of hepatocarcinogenesis
differently. Partial hepatectomy has been useful to
activate the initiation of preneoplastic foci (Scherer
& Emmelot, 1975, 1976; Barbason et al., 1975; Pitot
et al., 1978) but was generally useless as promoter,
except when combined with an inhibitor of cell
division (Solt & Farber, 1976; Becker & Klein,
1971; Hughes, 1969, 1970; Rabes & Szymkowiak,
1979). On the other hand, phenobarbital
counteracts the initiating phase when administered
simultaneously with the carcinogen (personal
observations; Weisburger et al., 1975; Kunz et al.,
1978; Peraino et al., 1971) but has been extensively
used as a promoter in other experimental systems
(Peraino et al., 1975; Pitot et al., 1978; Kitawaga et
al., 1979; Weisburger et al., 1975).
Materials and methods
Male Wistar rats, weighing 150-180g, were kept at
constant room temperature (22+2°C) with free
access to food (UAR.A03) and water. They were
only disturbed for necessary laboratory care.
Lighting 6 am-6 pm was artificial and automatic.
An air-conditioning system completely renewed the
air of the room every 3min. Animals were kept in
Macrolon cages (5 per cage) and divided into 5
different experimental groups.
In 3 groups, the animals received
diethylnitrosamine (DENA) administered in
drinking water (ingested dose - 10mgkg-1 per
day) for respectively 2, 4 and 6 weeks according to
an experimental scheme previously described
(Barbason & Betz, 1981). One week after the
cessation of DENA administration, animals were
submitted either to a 2/3 partial hepatectomy or to
phenobarbital (PhB) administration. The PhB
treatment (700mgl-' in drinking water; -15mg
per rat of ingested daily dose) was either limited in
time or continued up to death. In the case of a
limited PhB admonistration, the duration of
treatment was calculated to stop the drug in the 3
different sub-groups 10 weeks after the beginning of
DENA administration, i.e. 8 weeks of PhB after a
2-week DENA treatment, 6 weeks of PhB after
DENA for 4 weeks and 4 weeks of PhB after a 6-
week DENA administration.
The 2 other experimental groups were controls:
one group received a continuous PhB
administration and another one remained untreated.
During the experimental period (-2y), different
parameters were studied after various periods:
survival, changes in pathology, proliferation fraction
in preneoplastic lesion and in surrounding normal
tissue and mitotic response to the 2/3 partial
hepatectomy.
Survival
Survival curves were established in a probit/log grid
by plotting the surviving fraction after the death of
each animal. In each experiment there were >25
rats whose time of death was accurately known and
who were autopsied. Histological slides were
prepared from all the livers and from other organs
showing gross lesions.
Pathological changes
Every 3 months, 10 animals for each experimental
modality were killed. PAS positive foci retaining
glycogen after fasting, neoplastic nodules and
hepatomas were diagnosed according to Squire &
Levitt (1975) on histological preparations as
previously described (Barbason et al., 1977, 1979;
Barbason & Betz, 1980, 1981).
Proliferationfraction
Seven injections of triated thymidine ([3H]dT,
Amersham, 1 pCig-1 i.p.) given at 6h intervals label
all the cells entering DNA synthesis during the 36h
following the first injection. This labelling index
(L.I.) measures an actual hepatocyte "proliferation
fraction" and allows comparison of the growth rate
in preneoplastic foci and in phenotypically normal
parenchyma (Rabes & Szymkowiak, 1979). Classical
histoautoradiography was superimposed on the
PAS reaction so that the proliferation fraction was
measured at the same time in PAS-positive foci and
surrounding parenchyma. At least 5 rats were used
for each determination obtained by the method
previously described (Barbason & Betz, 1981).
Standard deviation of the mean of counts was
calculated. The Student t test was used to ascertain
the significance of the difference between the means.PROMOTION MECHANISM OF PHENOBARBITAL 519
Mitotic response to the partial hepatectomy
Mitotic response to the 2/3 partial hepatectomy
(performed at 10 am) including the circadian
rhythm of the mitoses was studied by measuring the
mitotic index on histological slides after Feulgen
reaction. The measurements were made up to the
72nd postoperative hour. In the figures, mitotic and
labelling indices represent the mean of the counts
calculated in 5 rats for each experimental modality.
Enough counts were made to obtain a standard
deviation below 25% of the mean value.
Results
Survival
In the controls, the mortality was nil up to the 30th
month but almost all animals were dead by 36
months. No death was recorded in animals treated
with PhB continuously for 24 months.
Figure 1 gives the survival curves of animals
receiving DENA alone for 2, 4 and 6 weeks. These
results are compared with those subsequently
obtained after DENA feeding followed either by
hepatectomy or PhB administration.
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Figure 1 Survival curves against time in probit-log
grid. Each point corresponds to the death of one
animal. Zero on abcissa corresponds to the beginning
of DENA feeding. Experimental groups: DENA for 2
weeks with cancer (0), without cancer (0); DENA
for 4 weeks with cancer (a), without cancer (LO);
DENA for 6 weeks with cancer (-), without cancer
(A).
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Figure 2 Survival curves against time in probit-log
grid. Each point corresponds to the death of one
animal. Zero on abcissa corresponds to the beginning
of DENA feeding. Experimental groups: DENA is
followed by 2/3 partial hepactomy in each group.
Symbols as in Figure 1.
On the other hand, animals continuously treated
with PhB after DENA feeding presented changes of
the response in all experimental modalities (Figures
1 and 3). In animals treated by DENA for 2 and 4
weeks before the PhB administration, survival
appeared slightly longer (-.2 months) but the
tumour incidence was significantly increased (80%
vs. 0% and 100% vs. 50% respectively). After a 6-
week DENA treatment, the median time of death
with cancer was reduced from 8.5 to 5.5 months.
In other experiments, DENA feeding was
followed by limited PhB administration, the total
duration of DENA plus PhB being 10 weeks
(Figure 4). In this case only, DENA for 6 weeks was
potentiated by a 4-week PhB administration and
the survival was approximately the same as when
PhB was given until death (5 months). In the two
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The 2/3 partial hepatectomy (Figure 2) did not
change the survival rate, except in animals operated
upon after a 6-week DENA treatment. In the last
case, death with cancer appeared to occur at the
same time in hepatectomized and non-
hepatectomized animals, but the median time of
death (50% lethality) decreases from 8.5 to 7
months.
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Figure 3 Survival curves against time in probit-log
grid. Each point corresponds to the death of one
animal. Zero in abcissca corresponds to the beginning
of DENA feeding. Experimental groups: DENA in
each group is followed by a continuous phenobarbital
treatment. Symbols as in Figure 1.
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Figure 4 Survival against time in probit-log grid.
Each point corresponds to the death of one animal.
Zero in abcissa corresponds to the beginning of
DENA feeding. Experimental groups: In each group,
DENA is followed by a limited phenobarbital
treatment. DENA for 2 weeks followed by
phenobarbital for 8 weeks: with cancer (a), without
cancer (0); DENA for 4 weeks followed by
phenobarbital for 6 weeks: with cancer (a), without
cancer (Cl); DENA for 6 weeks followed by
phenobarbital for 4 weeks: with cancer (A), without
cancer (A).
other experimental modalities (DENA for 2 and 4
weeks followed by PhB for 8 and 6 weeks
respectively) the complementarity treatment by PhB
seemed neither to decrease the median time of death
nor to increase the tumour incidence.
Pathological changes
As shown in Table I, the evolution of preneoplastic
foci to neoplastic nodules and the occurrence of
frank hepatomas diagnosed according to Squire &
Levitt (1975) was promoted by a continuous PhB
administration after DENA. After a 2-week DENA
feeding, which normally results in no neoplastic
response, the addition of PhB induces the
production of neoplastic nodules and hepatomas
are diagnosed at autopsy in 7/10 of the animals. In
animals fed with PhB after a 4-week DENA
administration, the occurrence of neoplastic nodules
and hepatomas was accelerated by 6 months. After
DENA administration for 6 weeks, most of the
PhB-fed rats presented neoplastic nodules or cancer
by 3 months after the start of the experiment. No
hepatic lesions were diagnosed either in untreated
control rats or in PhB continuously-treated rats.
The proliferationfraction
As shown in Table II, the L.I. was higher in PhB-
treated rats than in untreated controls; moreover, in
both groups, it decreased with ageing.
In DENA-fed rats, the L.I. was higher in
preneoplastic foci than in phenotypically-normal
parenchyma; in both locations, the proliferation
fraction increased with the duration of the DENA
administration. These last differences were not
statistically significant in all the experimental
modalities which were compared but corroborate
previous results obtained in the same conditions
(Barbason & Betz, 1981).
In animals receiving PhB after DENA, the L.I.
appeared to increase in comparison with those fed
with DENA alone. Furthermore, the increase
induced by PhB was more marked in preneoplastic
foci than in the normal liver parenchyma. This last
effect was statistically significant in all instances.
Table I Liver pathology at different intervals from the initiation of carcinogen
treatment (DENA for 2, 4, 6 weeks) followed by continuous phenobarbital (PhB)
administration or water
Months after the start ofDENAfollowed by
continuous phenobarbital administration4PhB)
3 6 12 14
Experimental modalities N H N H N H N H
+water 0 0 0 0 0 0 0 0
DENA 2 weeks
+PhB 0 0 0 0 3 0 10 7
+water 0 0 0 0 10 4
DENA 4 weeks
+PhB 1 0 10 9 10 10
+water 2 0 10 10
DENA 6 weeks
+PhB 6 3 10 10
For each experimental modality, 10 animals were examined. The figures indicate the
number of rats with positive findings of neoplastic nodules (N) and frank hepatomas
(H).
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Table II Labelling indices (labelled nuclei per 1000 nuclei after 7
injections of [3H]dT (lyCig-1, i.p.) at 6h intervals +s.d. based on 5
animals) measured in PAS positive preneoplastic areas and in the
corresponding phenotypically normal surrounding parenchyma in
various experimental groups: DENA for 2 and 4 weeks followed either
by continuous PhB administration or not-untreated young and old
rats-rats treated by PhB for short or long periods of time. Figures in
parenthesis correspond to significant differences between the means.
Normal areas PAS-positive areas
Untreated control
2 month old rats
Untreated control
12 month old rats
Phenobarbital for
10 days
Phenobarbital for
1 month
Phenobarbital for
12 months
DENA for 2 weeks
followed by water
for 12 months
DENA for 2 weeks
followed by PhB for
12 months
DENA for 4 weeks
followed by water
for 4 months
DENA for 4 weeks
followed by PhB for
4 months
9.1 +2(1)(2)
2.7+1(1X3)
35.0+5(2)(4)
7.2+2(4)
5.1+1(3)
12.0+2
17.4+2(5)
13.3 +3(6)
16.8 +3(7)
The mitotic response to partial hepatectomy
In untreated control rats, the mitotic pattern of
regeneration varied according to age (Figure 5). The
first mitotic wave with a clearly visible peak after
30h in 2 month-old rats was delayed and the peak
30-
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Figure 5 Mitotic index against time following a 2/3
partial hepatectomy (at 10 am). Experimental groups: 2
month- (0) and 14 month- (0) old rats. Shaded areas
represent the night phase.
15.3 +2(8X9)
43.7+9(5X3)
27.0+4(6X8X10)
40.2+4(7X)10)
shifted to the 48th post-operative hour in old
animals (14 months). This is in agreement with
previous observations (Bucher et al., 1964).
Nevertheless, in untreated control rats, of whatever
age, partial hepatectomy triggered a relatively rapid
mitotic response with a well-marked circadian
rhythm (see Figure 5).
After the DENA administration, the mitotic
response to partial hepatectomy, including the
circadian variations, decreased as a function of the
duration of carcinogen administration (Figure 6).
After DENA for 2 weeks, the response remained
well marked and the circadian rhythm was still
present. After DENA for 4 and 6 weeks, the mitotic
response decreased and the circadian rhythm
disappeared. It is noteworthy that the mitotic index
measured in the liver tissue resected at the time of
surgery increased with the duration of the previous
DENA administration.
In animals treated by PhB alone (Figure 7), the
mitotic response to hepatectomy was affected by the
drug. After PhB for one week, the first mitotic wave
occurred earlier and had better synchronization
than in the untreated controls (compare Figure 5);
the third mitotic wave, occuring at the 72nd post-522 H. BARBASON et al.
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Figure 6 Mitotic index against time following a
partial hepatectomy (at 10 am). Experimental
groups: Surgery performed after DENA for 2 weeks
(0), 4 weeks (O), 6 weeks (A); untreated controls of
the same age ( x ).
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Figure 7 Mitotic index against time following a 2/3
partial hepatectomy (at 10 am). Experimental groups:
Surgery performed in animals treated by phenobarbital
for 1 week (a), 4 weeks (0), 12 months (x); shaded
areas represent the night phase.
operative hour, also presented an exceptionally high
amplitude. After longer PhB administration (4
weeks, 12 months), the first mitotic wave decreased
and the first peak was progressively shifted to
longer post-operative delays; the synchronization of
the first cell division and the mitotic circadian
rhythm disappeared.
In the rats receiving DENA for 2 weeks, the
mitotic response to partial hepatectomy performed
4 or 12 months later was maintained with its
circadian rhythm. If the same DENA feeding was
followed by a continuous administration of PhB,
the mitotic response was decreased and developed
without any peak (compare Figures 8 and 9). A
similar response was found when DENA was given
for 4 weeks and PhB up to 4 months (Figure 10).
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Figure 8 Mitotic index against time following partial
hepatectomy (at 10 am) performed 4 months after the
start of DENA treatment. Experimental groups:
DENA for 2 weeks only (0), DENA for 2 weeks
followed by a continuous phenobarbital treatment (a),
controls at the same age (x).
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Figure 9 Mitotic index against time following partial
hepatectomy (at 10 am) performed 14 months after the
start of DENA treatment. Experimental groups as in
Figure 8.
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Figure 10 Mitotic index against time following partial
hepatectomy (at 10 am) performed 4 months after the
start of DENA treatment. Experimental groups:
DENA for 4 weeks only (0), DENA for 4 weeks
followed by a continuous phenobarbital treatment (@0),
controls of the same age (x).
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Discussion
The behaviour of DENA-treated liver cells is
differently influenced by partial hepatectomy and by
phenobarbital (PhB). It must be recalled that a 2/3
hepatectomy induces a mitotic response which
progresses by successive waves with a circadian
rhythm indicating homeostatic control of mitotic
activity.
After DENA administration for 2 weeks, the
homeostatic regulation remains approximately
normal (Van Cantfort & Barbason, 1975; Barbason
et al., 1976, 1977). In these conditions, partial
hepatectomy induces a rapid and rhythmic
regeneration; correlatively, there is no influence on
cancer development. On the contrary, after a 4-6
week DENA treatment, the homeostatic control is
progressively disturbed, the mitotic response to
partial hepatectomy is inhibited, the circadian
rhythm disappears and death with cancer is
accelerated.
Contrary to partial hepatectomy, PhB given
continuously after DENA favours the proliferation
advantage of preneoplastic foci, the subsequent
emergence of tumours and death from the disease.
Even after a sub-carcinogenic DENA
administration, continuous PhB treatment induces
tumours in - 80% of the animals.
PhB itself induces not only a slight increase of
mitotic activity in the liver, but also a severe
disturbance of homeostatic division and regulation.
In control rats, the continuous administration of
PhB increases at first (1 week treatment) the
synchronisation of mitotic activity and its circadian
rhythm after a partial hepatectomy (Tuczek et al.,
1975). Later on, it progressively inhibits the early
mitotic response and suppresses the circadian
pattern of regeneration. Thus, after a long period of
time, the acute and synchronized regeneration
response is changed into a chronic one.
It must be emphasized that PhB already induces
a preoperative background of proliferative activity.
This activity subsequent to PhB administration
occurs rapidly (after - 1 week) and thereafter
remains stabilized at a rather low value; contrary-
wise, the mitotic control disturbances induced by
PhB revealed by partial hepatectomy increase
progressively.
The promoting effect of PhB does not imply an
administration up to death. After DENA
administration for 2 and 4 weeks, which induces a
slight disturbance in mitotic control and
corresponds to the initiation of preneoplastic cells
(Barbason et al., 1976), PhB has no significant
promoting effect when applied for 8 and 6 weeks
respectively. But a 4-week PhB treatment is
sufficient to increase the effect of a previous 6-week
DENA treatment, after which the disturbance in
mitotic control is already very important and
carcinogenesis already promoted by DENA itself.
This suggests that a relatively short DENA
treatment acts as "initiator"; a promoting effect can
be obtained either by protracting the DENA
feeding or by switching to a chronic PhB
administration; the longer the DENA treatment, the
shorter the PhB administration necessary to
complete carcinogenesis. As previously observed by
protracting the DENA administration (Barbason et
al., 1979; Barbason & Betz, 1981), a critical stage of
cancer development is reached when neoplastic
nodules begin to appear and when mitotic control
is completely lost. When this stage is reached, no
further treatment either with DENA alone or
DENA plus PhB modifies the evolution of the
tumours.
Our results are in favour of a previously
proposed hypothesis (Scherer & Emmelot, 1975;
Williams et al., 1977; Pitot & Sirica, 1980), i.e. that
the induction of a selective growth of preneoplastic
foci depends on the type of proliferation induced: a
chronic low level of proliferation would be more
efficient than an acute liver regeneration. Partial
hepatectomy does not promote the effect of DENA
except when a mitotic disturbance is already
induced by a first DENA administration prolonged
to 6 weeks. In other experimental models, partial
hepatectomy performed after a short carcinogen
treatment has no strong promoting effect, except
when liver regeneration is already disturbed by a
mitotic inhibitor (Solt & Farber, 1976; Becker &
Klein, 1971; Hughes, 1969, 1970; Rabes &
Szymkowiak, 1979). The increased selective growth
of foci, leading to cancer development, could be
correlated with the occurrence of a prolonged
chronic proliferation caused by PhB (Peraino et al.,
1975).
In fact, chronic proliferation of liver cells, which
enhances the development of preneoplastic foci, also
disturbs the mitotic control (Argyris, 1971; Argyris
& Magnus, 1968). This has been shown as well in
animals treated by PhB after a first DENA feeding,
as in animals submitted to a continuous or
discontinuous DENA treatment (Rabes et al., 1970;
Barbason et al., 1976, 1977, 1979; Barbason & Betz,
1980, 1981).
The resistance of preneoplastic cells to the
cytotoxicity of the carcinogen or a promoting
substance has been suggested to explain the
selective growth of the lesions (Farber, 1980; Pitot
& Sirica, 1980; Emmelot & Scherer, 1980). Though
this hypothesis cannot be excluded, the present
results favour another mechanism based on the cell
kinetic changes.
The results of Rabes & Szymkowiak (1979)
indicate that the proliferation advantage of
preneoplastic cells may reside in a progressive524 H. BARBASON et al.
shortening of the cell cycle time during the
preneoplastic stage, the difference with normal cells
being slight at first.
When the regulation of mitotic control is normal,
successive circadian mitotic waves follow a cell loss
and the cells divide synchronously, without any
proliferation advantage. The result is homogeneous
tissue regeneration. On the contrary, when
homeostatic control is disturbed and when cell
growth is chronically maintained without any
synchronization, a proliferation advantage must be
progressively given to the cells presenting the
shortest cell cycle time. This could lead to a
multifocal nodular regeneration.
As previously concluded by discontinuing the
DENA administration (Barbason & Betz, 1981), the
promotion mechanism of tumour growth could
consist in a disturbance of the mitotic control for a
time long enough to permit the selective growth of
preneoplastic cells and cancer development.
This work has been supported by a grant of the
Fondation Braconier-Lamarche.
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